Background/Aims: The aim of this study was to determine the anti-psoriasis effects of α-(8-quinolinoxy) zinc phthalocyanine (ZnPc-F7)-mediated photodynamic therapy (PDT) and to reveal its mechanisms. Methods: HaCaT cells were used to observe the influence of ZnPc-F7-PDT on cell proliferation in vitro. The in vivo anti-psoriasis effects of ZnPc-F7-PDT were evaluated using a mouse vagina model, a propranolol-induced cavy psoriasis model and an imiquimod (IMQ)-induced nude mouse psoriasis model. Flow cytometry was carried out to determine T lymphocyte levels. Western blotting was performed to determine protein expression, and a reverse transcription-polymerase chain reaction test was performed to determine mRNA expression. Results: The results showed that ZnPc-F7-PDT significantly inhibited the proliferation of HaCaT cells in vitro; when the light doses were fixed, changing the irradiation time or output power had little influence on the inhibition rate. ZnPc-F7-PDT significantly inhibited the hyperproliferation of mouse vaginal epithelium induced by diethylstilbestrol and improved propranolol-and IMQ-induced psoriasis-like symptoms. ZnPc-F7-PDT inhibited IMQ-induced splenomegaly and T lymphocyte abnormalities. ZnPc-F7-PDT did not appear to change T lymphocytes in the mouse vagina model. ZnPc-F7-PDT downregulated the expression of proliferating cell nuclear antigen (PCNA), B-cell lymphoma-2 (Bcl-2), interleukin (IL)-17A mRNA and IL-17F mRNA, and up-regulated the expression of Bax. Conclusion: In conclusion, ZnPc-F7-PDT exhibited therapeutic effects in psoriasis both in vitro and in vivo and is a potential approach in the treatment of psoriasis. Potential mechanisms of these effects included the inhibition of hyperproliferation; regulation of PCNA, Bcl-2, Bax, IL-17A mRNA and IL-17F mRNA expression; and immune regulation.
Anti-Psoriasis Effects and Mechanisms of Α-(8-Quinolinoxy) Zinc PhthalocyanineMediated Photodynamic Therapy
Han-Qing Liu China). All animals were housed in cages at constant temperature and humidity and a 12 h light/dark cycle. Animals had free access to food and water. The study was approved by the Institutional Animal Care and Use Committee of the Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College. All operations were performed under the guidance of veterinarians according to international guidelines concerning the care and treatment of experimental animals.
Instruments and reagents
PDT-630 and PDT-670 semiconductor laser units were provided by Guilin Xingda Optoelectronic Medical Instrument Co., Ltd (Guangxi, China). ZnPc-F7 was provided by Beijing Guiqianjin Medical Technology Co., Ltd (Beijing, China); DVDMS was provided by Qing Long High Technology Co., Ltd. Antibodies were purchased from Sigma-Aldrich (USA). Primers for reverse transcription-polymerase chain reaction (RT-PCR) were synthesized by Invitrogen (USA). HaCaT cells were purchased from the Cell Resource Center of the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (Beijing, China).
Experiment 1: Effects of ZnPc-F7-PDT on cell proliferation in vitro
HaCaT cells were cultured in RPMI-1640 medium (HyClone, USA) containing 10% fetal bovine serum at 37°C with 5% CO 2 . Cells (2 × 10 5 /mL) were inoculated in 96-well plates with a volume of 100 μL per well. ZnPc-F7 was added after 24 h, with final concentrations of 0.01, 0.03, 0.10, 0.30, 1.00 and 3.00 μg/mL, and after 6 h cultivation the cells were exposed to a semiconductor laser unit for 180 s with a 1.50 W output power, and the energy density was 5.37 J/cm 2 . Cells treated with laser irradiation and ZnPc-F7 without PDT were included as controls. The MTT test was performed after additional 24 h cultivation. Absorbance values were measured using a microplate reader (ELX 800 UV; Dialab, Austria). The measurement wavelength was 545 nm, and the reference wavelength was 450 nm. To observe the influence of irradiation conditions, the spot diameter was set to 8 cm and the energy density was set to 5.37 J/cm 2 . The output power and irradiation time were set to 1.50 W and 180 s, 1.00 W and 270 s, 0.50 W and 540 s or 0.30 W and 900 s, respectively.
Experiment 2: Effects of ZnPc-F7-PDT on the hyperproliferation of mouse vaginal epithelium
In total, 70 female ICR mice were included and 60 were injected intraperitoneally with 0.20 mL of diethylstilbestrol (2.00 mg/mL) once daily for 3 consecutive days. On the fourth day, the mice were divided into seven groups: control group (Con), model group (M), ZnPc-F7 without PDT group (F7, 1.20 mg/kg), DVDMS-PDT group (DP, DVDMS 2.00 mg/kg), low dose ZnPc-F7-PDT group (LFP, ZnPc-F7 0.30 mg/kg), middle dose ZnPc-F7-PDT group (MFP, ZnPc-F7 0.60 mg/kg) and high dose ZnPc-F7-PDT group (HFP, ZnPc-F7 1.20 mg/kg). Mice in the PDT groups were exposed to lasers (PDT-630 for DVDMS and PDT-670 for ZnPc-F7) 6 h after intravenous drug injection. The output power was 0.10 W and irradiation time was 300 s. A 48 h light-avoiding period was carried out followed by a routine light/dark cycle. The mice were injected intraperitoneally with 4 mg/kg colchicine (Urchem, China, No.61601582) on the seventh day after PDT. Peripheral blood was collected to determine T lymphocytes using flow cytometry (FCM, BD Biosciences, USA). CD3 + , CD4
+ and CD8 + cells were marked by APC-Cy7-A, PE-Cy7-A and APC-A, respectively. The mice were then sacrificed with an overdose of 1% pentobarbital sodium. Vaginas were dissected and fixed in 10% formalin solution for histopathology. Hematoxylin-eosin (HE) staining was performed. A total of 300 basal keratinocytes were observed, and the mitotic rate was defined as the mitotic cell number in 100 basal keratinocytes.
Experiment 3: Effects of ZnPc-F7-PDT on propranolol-induced psoriatic lesions in cavy
Seventy of eighty Dunkin Hartley cavies (half male and female) were exposed to 5% propranolol liniment on both ears twice daily for 3 consecutive weeks. Three cavies were sacrificed with an overdose of 1% pentobarbital sodium at the end of each week and the degree of histopathology in the lesions was observed. On day 22, the cavies were divided into seven groups: control group (Con), model group (M), laser-control group (LC, irradiation only), ZnPc-F7 without PDT group (F7, 5% ZnPc-F7 liniment), DVDMS-PDT group (DP, DVDMS 0.75 mg/kg), low dose ZnPc-F7-PDT group (LFP, 1% ZnPc-F7 liniment) and high dose ZnPc-F7-PDT group (HFP, 5% ZnPc-F7 liniment). ZnPc-F7 liniment was prepared as follows: 0.95 mL polyoxyethylene castor oil was mixed with 25 mL N, N-dimethylacetamide, and 100 mg (for 1% liniment or 500 mg for 5% liniment) ZnPc-F7 was dissolved in 5 mL of the aforementioned mixture. Then, 500 mg polyoxyethylene pyrrolidone 30, 0.25 mL azone and 0.25 mL propylene glycol were added sequentially, and 50% ethyl alcohol was added to adjust the total volume to 10 mL.
Twenty-four hours after drug administration, PDT was performed in the last three groups. The output power, spot diameter and irradiation time were set to 1.00 W, 6 cm and 400 s, respectively, and the energy density was 14.15 J/cm 2 . A light-avoiding period was carried out for 48 h, and then a routine light/dark cycle was resumed. The second PDT was performed seven days later. All cavies were sacrificed with an overdose of 1% pentobarbital sodium with 7 days later, peripheral blood was collected to determine cytokines and reactive oxygen species using ELISA kits. Both ears were removed and fixed in 10% formalin solution for histopathology. A 3-D microscopic system (VHX-2000; Keyence, Japan) was used to observe and collect histopathology images. The thickness of the stratum spinosum was measured. Quantitative analysis of hyperkeratosis, abnormal stratum granulosum, irregular epidermal hyperplasia, clubbed papillary layer and hemangiectasis was performed using injury degree scores.
Experiment 4: Effects of ZnPc-F7-PDT on IMQ-induced psoriatic lesions in Nu/Nu mice
Seventy of eighty Nu/Nu mice (half male and female) were locally treated with 5% imiquimod (IMQ) cream on the dorsal skin once daily for 6 consecutive days. On the seventh day, these mice were divided into eight groups: control group (Con), model group (M), laser-control group (LC), ZnPc-F7 without PDT group (F7, ZnPc-F7 1.20 mg/kg), DVDMS-PDT group (DP, DVDMS 2.00 mg/kg), low dose ZnPc-F7-PDT (LFP, ZnPc-F7 0.30 mg/kg), middle dose ZnPc-F7-PDT (MFP, ZnPc-F7 0.60 mg/kg) and high dose ZnPc-F7-PDT (HFP, ZnPc-F7 1.20 mg/kg). All drugs were injected intravenously at the above doses. After 6 h, PDT was performed in the PDT groups. The output power, spot diameter and irradiation time were set to 0.10 W, 2 cm and 600 s, respectively, and the energy density was 19.10 J/cm 2 . A light-avoiding period was continued for 48 h, and then the routine light/dark cycle was resumed. Peripheral blood was collected on the eighth day for determination of T lymphocytes using flow cytometry (FCM). The mice were then sacrificed with an overdose of 1% pentobarbital sodium. The dorsal skin was removed and divided into three parts. One part was fixed in 10% formalin solution for histopathology, and the other two parts were stored in liquid nitrogen for Western blotting (WB) and RT-PCR analysis. The sequences of primers for RT-PCR were as follows: (1) 
Experiment 5: Mechanisms of ZnPc-F7-PDT in proliferation inhibition
Western blotting was performed to observe the expression of proliferating cell nuclear antigen (PCNA), B-cell lymphoma-2 (Bcl-2) and Bax. The procedure was as follows: A piece of skin was cut into small pieces and washed with phosphate-buffered solution (PBS). Lysis buffer (ThermoFisher, USA) containing 1% phenyl methane sulfonyl fluoride (ThermoFisher) was added at 2 μL/mg. The mixture was incubated at 4°C for 30 min and was then centrifuged at 12, 000 g for 30 min. The supernatant was removed and placed in a centrifuge tube, and protein quantification was performed with a micro-spectrophotometer (Q5000; Quawell, USA). The protein concentration was adjusted to 15.00 μg/mL and was then mixed with loading buffer. The mixture was incubated at 98°C for 10 min and was loaded after cooling. The loading volume of samples was 10.00 μL, and 10.00 μL of prestained dual-color protein molecular weight marker (ThermoFisher) was used to indicate the locations of proteins. The voltage was adjusted from 80 V to 120 V when the samples moved into the separation gel from the spacer gel, and the transfer time was 90 min with a voltage of 120 V. Polyvinylidene fluoride membranes were used to transfer proteins with a voltage 120 V for 90 min. The membranes were then blocked for 1 h at room temperature. After washing with Tris-buffered saline containing Tween (3 times × 10 min), the membranes were incubated with primary antibodies (overnight at 4°C) and then secondary antibody (1 h at room temperature), and were detected using a chemiluminescence detector (Image Quant LAS 4000 mini; General Electric Company, USA). The gray values of the protein bands were measured with ImageJ software and were compared with that of β-actin. TRIzol reagent (Invitrogen) and 200 μL chloroform were added successively. The mixture was held for 5 min at room temperature and then centrifuged for 15 min at 12, 000 g and 4°C. A 400 μL volume of supernatant was removed and placed in another RNase-free tube, and 400 μL isopropanol was added. The tube was held at room temperature for 10 min and was then centrifuged for 15 min at 12, 000 g and 4°C. The supernatant was removed, and 1000 μL precooled ethyl alcohol at a concentration of 95% was added. The tube was then centrifuged for 10 min at 12, 000 g and 4°C. The supernatant was removed, and 30 μL RNase-free water was added to dissolve the RNA. A micro-spectrophotometer was used to detect the concentration and purity of the RNA. RNA samples with OD260/OD280 values in the range of 1.8 to 2.2 were chosen for the next step. The cDNA was synthesized according to the RevertAid TM first-strand cDNA synthesis kit instructions (Fermentas, USA), and DNA was synthesized according to the Taq® green master mix kit instructions (Promega, Beijing, China). The volume of the reaction system was 25 μL. The gray values of the mRNA bands were measured with ImageJ software and were compared with that of GAPDH.
The levels of tumor necrosis factor-α (TNF-α), IL-1β, glutathione peroxidase (GSH-PX), superoxide dismutase (SOD) and malondialdehyde (MDA) in cavies' blood were determined with ELISA kits (Nanjing Jiancheng Bioengineering Institute, China; catalog numbers: TNF-α, 20151218; IL-1β, 20160106; GSH-PX, 20160803; SOD, 20160809; MDA, 20160910) according to the manufacturer's specifications.
Statistics
Data were expressed as the means ± SD and analyzed using the SPSS 17.0 software package. Oneway ANOVA was used to compare inter-group differences. A value of P < 0.05 was considered statistically significant.
Results

ZnPc-F7-PDT inhibited the proliferation of HaCaT cells
Laser irradiation (5.37 J/cm 2 ) without drugs did not inhibit the proliferation of HaCaT cells; however, ZnPc-F7 at the concentrations of 0.10, 0.30, 1.00 and 3.00 μg/mL showed dose-dependent inhibitory effects without PDT (P < 0.05, P < 0.01). The combined application of ZnPc-F7 and laser (ZnPc-F7-PDT) significantly improved the anti-proliferative effects at the concentrations of 0.10, 0.30 and 1.00 μg/mL (P < 0.01) (Fig. 1 A) . Changing the output power and irradiation time had little influence on the inhibition rate when the spot diameter and energy density were fixed (Fig. 1 B) .
ZnPc-F7-PDT inhibited diethylstilbestrol-induced hyperproliferation of mouse vaginal epithelium
Diethylstilbestrol induced hyperproliferation of mouse vaginal epithelium (Fig. 2 A) . The mitotic rate in the model group was significantly higher (P < 0.01) than that in the control group; middle and high doses of ZnPc-F7-PDT as well as DVDMS-PDT significantly inhibited the hyperproliferation of mouse vaginal epithelium (P < 0.05, P < 0.01); ZnPc-F7 (1.2 mg/kg) without laser irradiation did not significantly reduce the mitotic rate (Fig. 2 B) . Diethylstilbestrol did not significantly influence CD3 + , CD4 + and CD8 + or CD4 + /CD8 + levels, and these levels were not significantly different in all groups (Fig. 2 C) .
ZnPc-F7-PDT improved propranolol-induced psoriatic lesions in cavies
Local application of 5% propranolol for 3 weeks induced psoriatic lesions on the ears of cavies. The changes were obvious in appearance and histopathology (Fig. 3) . Normal ears were smooth and covered with hairs. Following local application of 5% propranolol for 1 week, the ears were bare and silvery scales were observed. At the end of week 2, a greater number of silvery scales were observed and the ears were thickened. Sections of the blood vessels were expanded, and pain reactions that were present initially disappeared. At the end of week 3, ear thickness increased further; however, the silvery scales were smaller and fewer than before. Classic characteristics of psoriasis, including inflammatory cell infiltration, hyperkeratosis, parakeratosis, hemangiectasis, abnormal stratum granulosum, acanthosis, irregular epidermal hyperplasia and clubbed papillary layer, appeared successively. Munro microabscesses were uncommon. After 2 weeks' recovery, the ears showed no apparent differences compared with normal animals. However, the histopathology characteristics were still present, with the exception of inflammatory cell infiltration. + levels, and the levels were not significantly different in all groups. splenomegaly and liver injuries (Fig. 6 A) . ZnPc-F7-PDT inhibited the psoriatic symptoms induced by IMQ, as did DVDMS-PDT (Fig. 6 B) . The body weight and spleen coefficient of the model group were significantly different compared with the control group (P < 0.05, P < 0.01) (Fig. 6 C and D) ; middle and high doses of ZnPc-F7-PDT significantly inhibited the increase in spleen coefficient induced by IMQ (P < 0.05); the other groups exhibited no significant difference in the spleen coefficient compared with the model group; the coefficients of heart, liver, lung and kidney showed no significant differences among the groups (Fig. 6 D) .
The FCW test showed that the CD4 + level in the model group was decreased and the CD8 + level was higher than that in the control group (Fig. 6 E) , which induced abnormal CD4 + /CD8 + levels ( Fig. 6 F) ; ZnPc-F7-PDT had a tendency to correct the abnormal CD4 + /CD8 + levels by increasing the CD4 + level and decreasing the CD8 + level: however, there were no significant differences compared with the model group (Fig. 6 E and F) . .01, compared with the model group. Con: control group, M: model group, LC: laser-control group, F7: ZnPc-F7 without PDT group, DP: DVDMS-PDT group, LFP: low dose ZnPc-F7-PDT group, HFP: high dose ZnPc-F7-PDT group. A: Standard for evaluation, psoriatic characteristics, including hyperkeratosis (1), abnormal stratum granulosum (2), epidermal hyperplasia (3), clubbed papillary layer (4) and hemangiectasis (5), were quantitatively analyzed under Z100 × 400 views (HE staining, 3-D microscopic system as previously given). Asymptomatic, mild, moderate and serious characteristics of (1) - (5) were scored as 0, 0.5, 1 and 1.5, respectively. The total scores of all characteristics were calculated. B: Effects of ZnPC-F7-PDT on psoriatic characteristics. The scores of the model group were significantly higher than those of the control group; ZnPc-F7-PDT significantly reduced the total score, as did DVDMS-PDT. Laser and ZnPc-F7 alone did not significantly influence the psoriatic characteristics. 
ZnPc-F7-PDT influenced protein expression of PCNA, Bax and Bcl-2
The WB results showed that IMQ induced the up-regulation of PCNA and Bcl-2 and the down-regulation of Bax (P < 0.05, P < 0.01) (Fig. 7 A) . A high dose of ZnPc-F7-PDT significantly down-regulated the expression of PCNA and Bcl-2 and up-regulated the expression of Bax, as did DVDMS-PDT (P < 0.05, P < 0.01) (Fig. 7 A) .
ZnPc-F7-PDT influenced mRNA expression of IL-17 A and IL-17 F
The results showed that IMQ significantly up-regulated the mRNA expression of IL-17A and IL-17F (P < 0.01); middle and high doses of ZnPc-F7-PDT as well as DVDMS-PDT significantly down-regulated the expression of IL-17A and IL-17F (P < 0.05, P < 0.01) (Fig.  7 B) .
Influence of ZnPc-F7-PDT on inflammatory factors and reactive oxygen species in cavies'
blood No significant differences were observed in TNF-α, IL-1β, SOD and MDA levels between the groups. The GSH-PX content in the F7 group was significantly higher than that in the control and model group (P < 0.05); however, GSH-PX content in the LC group, DP group, LFP group and HFP group were not significantly different compared with the control group and model group (Fig. 8) .
Discussion
HaCaT cells are frequently used in anti-psoriasis research in vitro [19] . Byun et al. [20] observed cytokine expression in cultured HaCaT cells after intense pulse light (IPL) treatment or PDT utilizing 5-aminolevulinic acid and IPL at sublethal doses. The results showed that IL-10 protein increased after IPL treatment and PDT; TGF-β1 mRNA and protein increased after both IPL treatment and PDT. In the present study, HaCaT cells were used to determine A: IMQ induced psoriatic lesions and organ changes including parakeratosis, hyperkeratosis, abnormal stratum granulosum, acanthosis and irregular epidermal hyperplasia; and induced splenomegaly and liver injuries, HE staining, Z100 × 100. B: Influence of ZnPc-F7-PDT on IMQ-induced psoriatic lesions; ZnPc-F7-PDT inhibited the psoriatic symptoms induced by IMQ, as did DVDMS-PDT. C: Body weight, the body weight of the model group was significantly different compared with the control group; however, body weights of all experimental groups were not significantly different to the control group or the model group. D: Organ coefficients, middle and high doses of ZnPc-F7-PDT significantly inhibited the increase in spleen coefficient induced by IMQ; the coefficients of heart, liver, lung and kidney showed no significant differences among the groups. E: Lymphocyte (LYM) levels, the CD4 + level in the model group was decreased and the CD8 + level was higher than the control group and high dose ZnPc-F7-PDT significantly increased the CD4 + level compared to the model group. F: CD4 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry induced the hyperproliferation of mouse skin and inhibited its normal apoptosis. ZnPc-F7-PDT down-regulated Bcl-2 expression and up-regulated Bax expression, which appeared to be a potential mechanism for inhibition of psoriatic skin hyperproliferation. Current knowledge of the immunopathogenesis of psoriasis is based on the crucial role of CD4 + and CD8 + lymphocytes. The expression of CD4 + lymphocytes and CD8 + lymphocytes was found to be significantly altered in psoriasis patients [33, 34] . In the present study, we found that IMQ induced an increase in the spleen coefficient and abnormalities in the CD4 + / CD8
+ ratio compared with the control. ZnPc-F7-PDT restored the spleen coefficient and the CD4 + /CD8 + ratio to normal levels. However, in the mouse vagina model, ZnPc-F7-PDT did not change the CD4 + /CD8 + level, which suggested that ZnPc-F7-PDT had immunomodulatory effects, but did not influence the normal immunity of animals and may be very useful in the treatment of psoriasis.
IL-17 is the defining cytokine in the Th17, Tc17, and γδ T cell populations, and play critical roles in mediating inflammation and autoimmunity. IL-17 plays important roles in the pathogenesis of psoriasis and IL-17 inhibitors are considered important agents in the management of psoriasis [35] [36] [37] [38] . The RT-PCR results in our study showed that IMQ induced the up-regulation of IL-17 A mRNA and IL-17 F mRNA in mouse skin, whereas ZnPc-F7-PDT down-regulated their expression, which is another potential mechanism of ZnPc-F7-PDT in the treatment of psoriasis.
Oxidative damage plays an important role in the treatment of cancers using PDT, and reactive oxygen species (ROS), such as 1 O 2 , are an important pathway by which cells are killed by PDT [39] . Skin is a major target of oxidative stress, mainly due to ROS originating from the environment and metabolism. Increased or prolonged presence of free radicals can override ROS defense mechanisms and mediate numerous cellular responses that contribute to the development of a variety of skin disorders, including psoriasis [40] . Recent reports have proposed opposing views. Kim et al. [41] investigated IMQ-induced psoriatic dermatitis in association with Treg function both in elevated and lowered levels of ROS and found that IQM-induced psoriasis was attenuated at elevated levels of ROS and was aggravated at reduced levels of ROS. Furuhashi et al. [42] found that photo (chemo) therapy reduced circulating Th17 cells and restored circulating regulatory T cells in psoriasis. Our results showed that ZnPc-F7-PDT inhibited the expression of IL-17 mRNA and reduced the psoriatic lesions induced by IMQ. However, the influence of ZnPc-F7-PDT on Th 17 cells requires further study.
Conclusion
ZnPc-F7-PDT is a potential treatment option for psoriasis. Inhibition of hyperproliferation, down-regulation of the expression of IL-17 mRNA and immune regulation effects are possible mechanisms. However, in our previous studies, ZnPc-F7-PDT did not significantly influence the formation of stratum granulosum in a mouse tail test. Thus, it is necessary to confirm the effects of ZnPc-F7-PDT in parakeratosis. Moreover, the roles of ZnPc-F7-PDT in signal transduction require further study.
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